1645 results about "Biologic Agents" patented technology

A prosthetic screw system that includes a prosthetic screw for at least partial insertion into a bone and/or cartilage. The prosthetic screw includes a head and a lower portion connected to the head. The prosthetic screw system also includes a set of head-pieces that can be connected to the head of the prosthetic screw. The head-pieces have differing configurations that are designed to be connected to different types of components of a prosthetic system. The universal connection arrangement between the prosthetic screw and the set of head-pieces enables the prosthetic screw to be customized for connection with a variety of components of a prosthetic system. The head-pieces can alternatively or additionally include a mechanical and/or electrical mechanism that provides one or more substances (e.g., medicine and/or other biological agent, etc.) and/or electrostimulation to a surgical site.

The present invention provides a flowable composition suitable for use as a controlled release implant. The flowable composition can be administered into the ocular region of a mammal. The composition includes: (a) a biodegradable, biocompatible thermoplastic polymer that is at least substantially insoluble in aqueous medium, water or body fluid; (b) a biological agent, a metabolite thereof, a biological agently acceptable salt thereof, or a prodrug thereof; and (c) a biocompatible organic liquid, at standard temperature and pressure, in which the thermoplastic polymer is soluble. The present invention also provides methods of medical treatment that include administering the flowable composition into the ocular region of a mammal.

Chemical and biological detector systems, devices and apparatus. Such devices may be portable and wearable, such as badges, that are analyte-general, rather than analyte-specific, and which provide an optimal way to notify and protect personnel against known and unknown airborne chemical and biological hazards. The devices of the present invention are advantageously low-cost, have low-power requirements, may be wearable and are designed to detect and alarm to a general chemical and biological threat. A sensor device of the present invention in one embodiment includes two or more sensor devices, a processing module coupled to each of the sensor devices and configured to process signals received from each of the two or more sensor devices to determine an environmental state; and a communication module that communicates information about the environmental state to a user.

Compositions and methods for enhancing delivery of molecules, e.g. biological agents, into cells are described. The composition is a conjugate of the biological agent, preferably a nucleic acid analog having a substantially uncharged backbone, covalently linked to a peptide transporter moiety as described. Conjugation of the peptide transporter to a substantially uncharged nucleic acid analog, such as a morpholino oligomer, is also shown to enhance binding of the oligomer to its target sequence and enhance antisense activity.

A medical device that is at least partially formed of a biodegradable polymer. The medical device can be at least partially formed by MEMS technology. The medical device can include one or more micro-structures that are also formed by MEMS technology. The medical device can include one or more biological agents that can be controllably and/or uncontrollably released from the medical device,

Disclosed are mixtures and compositions for controlling invertebrate pests relating to combinations comprising (a) 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide, and its N-oxides, and suitable salts thereof

and a component (b) wherein the component (b) is at least one compound or agent selected from neonicotinoids, cholinesterase inhibitors, sodium channel modulators, chitin synthesis inhibitors, ecdysone agonists, lipid biosynthesis inhibitors, macrocyclic lactones, GABA-regulated chloride channel blockers, juvenile hormone mimics, ryanodine receptor ligands, octopamine receptor ligands, mitochondrial electron transport inhibitors, nereistoxin analogs, pyridalyl, flonicamid, pymetrozine, dieldrin, metaflumizone, biological agents, and suitable salts of the foregoing. Also disclosed are methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a mixture or composition of the invention.

A composite biological agent with ternary microorganism for composting process of agricultural waste is composed of a composite biological agent I, a composite biological agent II, and a composite biological agent III, which is characterized in that the composite biological agent I is composed of bacillus, actinomycetes, microzyme and lactobacillus, the composite biological agent II is composed of trichoderma, ergillus, penicillium and trametes versicolor, and the composite biological agent III is composed of photosynthetic bacterium, azotobacter, phosphorus bacteria, and silicate bacterium. 30-60% composite biological agent I, 30-60% composite biological agent II, 10-20% composite biological agent III are mixed or applied to the process of composting process of agricultural waste in phases. Each component ratio and recruitment of biological agents can be both properly adjusted with different dung materials and dung purpose, thereby achieving purpose of using microorganism resources efficiently and raising fermentation efficiency.

The invention provides surgical devices that provide access to the sub-retinal space using delicate traction to hold the sensory retina to create and maintain a patent sub-retinal space of sufficient size to introduce and perform treatments on the eye. Such treatments may include the introduction of illumination or imaging agents or tools, surgical tools, the infusion of pharmaceutical or biological agents, and the placement of grafts, transplants or implants and the closure of the site through the delivery of a sealant.

The invention is directed to methods and compositions for preparing matrices for controlled delivery of at least one therapeutic or biological agent to a target site in a subject. This is accomplished using nanoparticles coupled to the therapeutic or biological agent that are incorporated within the matrix or reacted on the surface of the matrix.

The invention is a system and method for handling items to be shipped that securely verifies the sender. The invention makes use of pre-printed, unique, labels which are affixed by hand or machine to items to be mailed or shipped. These labels are packaged and distributed in groups. The groups of labels can be sold or freely distributed. Each person or organization that originates shipments is assigned a unique customer account number and their identity is authenticated when this account is created. The group number for a group of labels is linked to a customer account prior to the use of any of the labels from the group. The linking can be done at the time of sale or distribution of the group of labels, or after the sale or distribution thereof. Post-sale linking of a group of labels to a customer account can be done over the phone or through a web-site. The invention overcomes limitations in the prior art by creating a method for authenticating the sender of each item without requiring the use of a computer, printer, postage machine, or any other specialized hardware by the sender. The unique label identifiers are stored in a database that is used to ensure that each label that can be used only once. The invention is suitable for bulk mail processing and individual mail items. The invention provides a method for making selective use of specialized handling equipment, including equipment to irradiate the mail to destroy biological agents.

A method for enhancing the uptake of a therapeutic biological agent by treated cells. A low-power, unfocused field of acoustic energy is directed at the treated cells after the delivery of the therapeutic agent to the treated cells. A related method for stimulating either neural cells or cells in a cell culture. A portable sized device provides the field, and may include either an array of emitters or a scanable emitter.

A method of evaluating drug efficacy of experimental pharmaceutical agents or biological agents proposed for the treatment of arterial plaque burden is described herein. Arterial plaque from a first appendage is removed and analyzed for the content of one or more markers. One or more test pharmaceutical agent or biological agent alone or in combination are administered to the patient for a specified period of time equal to a period of time after which it is supposed that a marker level will have changed in response to the drug. Arterial plaque is then removed from a second appendage and analyzed for the same marker or markers as the first plaque tissue in order to determine whether the test pharmaceutical agent or biological agent was efficacious in altering the production of the marker in the patient.

Asymmetric bifunctional silyl (ABS) monomers comprising covalently linked pharmaceutical, chemical and biological agents are described. These agents can also be covalently bound via the silyl group to delivery vehicles for delivering the agents to desired targets or areas. Also described are delivery vehicles which contain ABS monomers comprising covalently linked agents and to vehicles that are covalently linked to the ABS monomers. The silyl modifications described herein can modify properties of the agents and vehicles, thereby providing desired solubility, stability, hydrophobicity and targeting.

The invention discloses an enteric-solubility multilayer encysted bacterium microcapsule and making method in the biological agent technical domain, which is characterized by the following: adopting sodium alginate, calcium chloride and chitose as clad material of microcapsule; making lactic acid bacteria or bifidobacteria as core-clad material; proceeding ionic exchange for sodium alginate and calcium chloride; forming second clad on the surface of calcium alginate through different isoelectric points of calcium alginate and chitose; freezing at low temperature to obtain the product.

The present invention provides a catch and snare system for an unmanned aerial vehicle comprising: (a) a detection system, (b) a deployment system in communication with the detection system, (c) a capture system placed at an interference position by the deployment system, wherein the capture system comprises a net, a plurality of foam deploying canisters attached to the net for deploying foam, and at least one canister for deploying a decelerating parachute attached to the net, wherein the foam prevents the release of chemical or biological agents from the captured unmanned aerial vehicle, and (d) a descent system to bring the capture system and a captured unmanned aerial vehicle back to earth.

Embodiments of the invention relate to a curable nucleus pulposus implant having water absorption and swelling capabilities, compositions for producing the curable nucleus pulposus implants, and methods of using the curable nucleus pulposus implants. The curable nucleus pulposus implant can be created from a polymer blend composition comprising a ratio of a curable material and at least one hydrophilic polymer. The resulting polymer blend composition may be used to generate curable nucleus pulposus implants to treat a number of disease and/or disorders, such as herniated discs. The curable nucleus pulposus implants may further contain polyelectrolytes and elastomer compounds, as well as pharmacological and biological agents.

A system and related methods for maintaining the patentcy of the ureter comprising a pusher tube having a pusher tube lumen and an inflate lumen disposed within a wall of the pusher tube and a urinary stent having a proximal and distal portions with an elongated body portion therebetween configured to fit the ureter of the patient and defining a lumen. The system further includes an end-effector that may comprise an inflatable balloon positioned at the proximal portion of the urinary stent for retaining the proximal portion in the urinary bladder. At the distal portion, a retention end-piece is positioned for retaining the distal portion of the stent in the renal pelvis. The end-effector and the retention end-piece of the stent maintain the elongated body portion in situ. The end-effector may also include an inflatable balloon and may contain pharmaceutical or biologic agents for controlled release into the bladder.

An array of piezoelectric resonators used in a sensor device in order to identify chemical and biological agents. The resonators can operate as bulk acoustic wave (BAW), surface acoustic wave (SAW), or Love mode devices. The sensor device integrates gravimetric, calorimetric, thermal gravimetric, voltage gravimetric and optical detection methods into one sensor system, improving the accuracy of identifying hazardous agents. For gravimetric detection, dual-mode resonators provide simultaneous calorimetric and gravimetric data, one type from each mode. Resonators with heaters on the surfaces will provide thermal gravimetric data. An optical detector can be used to analyze the optical signal from the surface of a coated resonator. Additionally, voltage gravimetric measurements can be made with an electric field set up between the resonator and an external electrode. Thermal voltage gravimetric measurements can be made by adding an integrated heater on the resonator with an external electrode. An alarm can be activated upon the identification of a hazardous agent. The sensor device can utilize other valuable information, including traceable time, GPS location, and variables related to temperature, humidity, air speed, and air direction.